IDEXX Laboratories (IDXX)
(Delayed Data from NSDQ)
$535.54 USD
+1.23 (0.23%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $535.67 +0.13 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, IDEXX Laboratories, Inc. has a market cap of $42.97B, which represents its share price of $534.31 multiplied by its outstanding shares number of 80.42M. As a large-cap company, IDXX's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
IDXX 535.54 +1.23(0.23%)
Will IDXX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IDXX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IDXX
Integra LifeSciences (IART) Beats Q2 Earnings and Revenue Estimates
Idexx (IDXX) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
IDXX: What are Zacks experts saying now?
Zacks Private Portfolio Services
AxoGen (AXGN) Earnings Expected to Grow: Should You Buy?
Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy?
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Other News for IDXX
Here are the major earnings before the open Monday
IDEXX Laboratories Q2 2025 Earnings Preview
Earnings Outlook For IDEXX Laboratories
Baron Focused Growth Fund Q2 2025 Shareholder Letter
Why Investors Are Eyeing IDEXX Laboratories Inc (IDXX): The Key Drivers of Market ...